Barclays Maintains an 'Overweight' on UnitedHealth Group (UNH); Investor Day Shows Continued Evolution

Barclays maintains an 'Overweight' on UnitedHealth Group (NYSE: UNH) price target raised $1 to $61.00.

Barclays analyst says, "With the presentation of detailed financial guidance, we are updating our estimates for 2011 and 2012. First, we are raising our EPS estimate for 2011 to $4.55 per share, which mainly reflects the company's previous announcement that it expects to take its one-time charge related to the Penn Treaty matter in 2012, rather than 4Q11, as it previously expected. For 2011, we are increasing our estimate to $4.65 per share, up from $4.60, which is at the midpoint of the company's guidance range of $4.55-4.65. We have made some other tweaks to our segment and quarterly estimates given remarks from the investor day."

For an analyst ratings summary and ratings history on UnitedHealth Group click here. For more ratings news on UnitedHealth Group click here.

Shares of UnitedHealth Group closed at $45.88 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Industry Veteran Jeff Mellios Joins The SSI Group to Lead Next Chapter of Payer Solutions Business Growth
• Benchmark Reiterates Buy Rating on Rank One Computing (ROC)
• Ferrovial SA (FER:SM) (FRRVF) Reiterated at Buy by UBS on Winning Bid For Tennessee Project